Objectives: Kita-Kyushu lung cancer antigen-1 (KK-LC-1) is a cancer/testis antigen reactivated in several human malignancies. So far, the major focus of studies on KK-LC-1 has been on its potential as diagnostic biomarker and immunotherapy target.
| INTRODUC TI ON
Hepatocellular carcinoma (HCC) is one of the most common and aggressive tumours worldwide. 1 Although successful partial hepatectomy and liver transplantation have markedly improved survival, patients with HCC typically have poor prognosis. Elucidation of the molecular mechanisms underlying HCC progression is critical for identifying novel therapeutic targets and improving the prognosis of HCC patients.
Cancer/testis (CT) antigens are a well-defined class of proteins that have been pursued as potential targets for anti-cancer therapy.
Cancer/testis antigens are typically restricted to gametes and trophoblasts in normal tissues but are aberrantly expressed in a range of human cancers. 2, 3 Kita-Kyushu lung cancer antigen-1 (KK-LC-1), encoded by CT83 or Cxorf61 gene, has been characterized as a CT
antigen. KK-LC-1 is expressed in 40% of non-small-cell lung cancer tissues, 4 81.6% of gastric cancer 5 and 75% of triple-negative breast cancer. 6 The expression rate of KK-LC-1 in human malignancies is markedly higher than the rates of other CT antigens. Correlated with
Helicobacter pylori infection, 7 KK-LC-1 can be frequently detected even in early stage of gastric cancer 8 and at the pre-cancerous condition of the stomach. 9 KK-LC-1 is cancer cell selective and immunogenic, and expressed at high level and frequency in cancers, 6 making it an ideal cancer immunotherapy target. A recent study has implicated the utility of KK-LC-1 as a target for photodynamic therapy in malignancies. 10 However, the biological functions and underlying mechanisms of KK-LC-1 in human cancers remain obscure.
The Notch signalling is one of the well-conserved pathways that are involved in multicellular organism development and homeostasis. Activation of Notch signalling helps to modulate fundamental intracellular processes, including cell cycle regulation, cell differentiation and apoptosis. 11 Dysregulated Notch signalling could result in various diseases, such as leukaemia, Alagille syndrome, pulmonary arterial hypertension and ventricular septal defect. 12 Perturbations of Notch signalling as well as its regulatory molecules have been observed in various cancers. In breast cancer, JAG1 activates Notch signalling and promotes tumour metastasis. 13 Inhibition of Notch1/2 could suppress cell proliferation in renal cell carcinoma. 14 Notch1 overexpression leads to enhanced tumour growth in melanoma. 15 Notch signalling has been reported to be activated in HCC and promotes liver tumour formation. 16 Upon ligand binding, Notch undergoes a series of cleavage events to generate its activated form NICD.
γ-Secretase mediates the last step of the cleavage and fine-tunes the level of NICD in cytoplasm. 17 As a catalytic subunit of γ-secretase complex, presenilin-1 contributes to the intricate regulation of the Notch signalling. 18 A previous study mapped the landscape of CT genes in 19 cancer types 19 
| ME THODS AND MATERIAL S

| Patient samples
We obtained paired HCC and adjacent non-tumorous liver tissues from 60 patients who underwent surgical resection in the First 
| Cell lines and cell culture
Human hepatic cell line QSG-7701 and HCC cell lines SMMC7721, HepG2, Hep3B, HLF, Focus and Huh7 were obtained from the Chinese Academy of Sciences Cell Bank (Shanghai, China). HCCLM3
cell line was acquired from Liver Cancer Institute, Zhongshan
Hospital, Fudan University (Shanghai, China). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Gibco, Thermo Fisher Scientific, Carlsbad, CA, USA) supplemented with 10% foetal bovine serum (FBS), 100 units/mL penicillin and 100 μg/mL streptomycin.
All cells were maintained in a 37°C incubator with an atmosphere of 5% CO 2 .
| RNA extraction and quantitative real-time polymerase chain reaction (RT-qPCR)
TRIzol reagent (Invitrogen, Carlsbad, CA, USA; Thermo Fisher Scientific) was used to extract total RNA from tissues and cells. cDNA synthesis was performed with PrimeScript RT Master Mix (TaKaRa, Dalian, China), and RT-qPCR was performed using TB Green Premix
Ex Taq (TaKaRa) on the Applied Biosystems 7900HT Fast Real-Time
Conclusions:
This study identified that hypomethylation-induced KK-LC-1 overexpression played an important role in HCC progression and independently predicted poor survival. We defined the KK-LC-1/presenilin-1/Notch1/Hes1 as a novel signalling pathway that was involved in the growth and metastasis of HCC.
PCR System (Applied Biosystems, Foster City, CA, USA; Thermo Fisher Scientific). GAPDH was used as the internal control. The 2 -ΔΔCt method was employed to analyse the relative expression. The PCR primers used are presented in Table S1 .
| Western blot analysis and coimmunoprecipitation
Western blot was performed using an SDS-PAGE Electrophoresis
System as described previously 20 
| Immunohistochemistry analysis and immunofluorescence
Expression of KK-LC-1, PCNA, E-cadherin, vimentin and NICD1 was evaluated using an immunohistochemical method described previously. 20 The intensity of immunohistochemical staining was set as 0 for negative, 1 for weak, 2 for medium and 3 for strong. The percentage of stained area was scored as 0 for 0%-10%, 1 for 11%-25%, 2 for 26%-50%, 3 for 51%-75% and 4 for 76%-100%. The overall staining score was calculated by multiplying the intensity score and staining area score as previously described. 20 Immunofluorescence was carried out as previously reported. Table S1 .
| Cell proliferation assays
Cell Counting Kit-8 (CCK-8), 5-ethynyl-2'-deoxyuridine (EdU) incorporation assay and colony formation assay were carried out as described in previous study. 21 
| Cell migration and invasion assays
Cell migration and invasion were evaluated with transwell inserts coated without Matrigel (for the migration assay) or with Matrigel (for the invasion assay) as reported previously. 
| Methylation-specific PCR (MSP)
Genomic DNA from HCC tumour tissues and noncancerous liver tissues was extracted using the TIANamp Genomic DNA Kit (TIANGEN Biotech, Beijing, China) according to the manufacturer's instructions. DNA was subjected to sodium bisulphite treatment using the Methylation-Gold Kit (Zymo Research Corporation, Irvine, CA, USA). Forward and reverse primers for the methylated sequence (M) and the unmethylated sequence (U) are listed in Table S1 .
| Bisulphite sequencing PCR (BSP)
Genomic DNA was treated with bisulphite using the Methylation- Table   S1 . The coverage of product of the primer was between −90 and +250 bp (NC_000023.11: c116463123-116462783) from transcription start site of the CT83 gene and contained 17 CpG sequences.
The modified DNA was amplified using the specific sequencing PCR primers. The 341-bp PCR products were cloned into pMD.19-T Vector (TaKaRa). At least ten independent colonies of each sample were sequenced by GeneCreate (Wuhan, China). nificance was concluded at *P < 0.05, **P < 0.01, ***P < 0.001.
| Statistical analysis
| RE SULTS
| KK-LC-1 is frequently overexpressed in HCC and serves as a prognostic indicator
To understand the role of KK-LC-1 in liver cancer, we first determined the expression levels of KK-LC-1 in 60 pairs of HCC samples and ad- into high KK-LC-1 level group and low KK-LC-1 expression group.
As shown in Table S2 . In addition to the TCGA data, we conducted survival analysis on the recruited 60 HCC patients from our centre.
Our data suggested that KK-LC-1 overexpression correlated with poor overall survival ( Figure 1H ; P = 0.0018) and high probability of recurrence ( Figure 1I ; P = 0.0128). Cox proportional hazards regression model was employed to perform the multivariate survival analysis on the 60-patient cohort. As shown in 
| KK-LC-1 is required for the maintenance of malignant phenotypes of HCC cells
To understand the functional role of KK-LC-1 in HCC cells, we first performed knockdown of KK-LC-1 via shRNA in SMMC7721 and HCCLM3 with high levels of KK-LC-1. Three shRNAs (sh1-KK-LC-1, sh2-KK-LC-1 and sh3-KK-LC-1) were designed to knock down KK-
LC-1 expression. Expression level of KK-LC-1 was determined by
RT-qPCR and Western blot; sh1-KK-LC-1 was the most effective one F I G U R E 1 KK-LC-1 is frequently overexpressed in HCC and serves as a prognostic indicator. A, The expression level of KK-LC-1 mRNA was compared between 60 paired HCC (T) and adjacent non-tumorous (N) tissues using RT-qPCR. GAPDH was used for normalization. B, KK-LC-1 mRNA expression level was elevated in 60 paired HCC tissues compared to that in adjacent non-tumorous samples. Wilcoxon signed-rank test was adopted to analyse the difference between the groups. The data are shown as the mean ± SE. ***P < 0.001. Additionally, transwell assays were performed, and we found that KK-LC-1 promoted HCC cell migration and invasion ( Figure 2F and Figure 3F ).
| KK-LC-1 is associated with EMT process in HCC
Previous reports have indicated that a number of CT antigens induce EMT in human malignancies. 23 Therefore, we speculated that KK-LC-1 might be involved in the EMT process. sh-KK-LC-1 HCCLM3 cells exhibited cobblestone-like epithelial morphology, whereas the F I G U R E 2 KK-LC-1 knockdown suppresses HCC cell proliferation, migration and invasion in vitro. A, KK-LC-1 expression in SMMC7721 and HCCLM3 was stably knocked down using shRNA. RT-qPCR was performed to assess the knockdown efficiency. B, Western blot was conducted to evaluate the effects of sh-KK-LC-1 on SMMC7721 and HCCLM3 cells. C, CCK-8 assays were used to analyse cell proliferation in HCC cells with KK-LC-1 knockdown. D, EdU assays were performed to examine the effects of KK-LC-1 knockdown on HCC cell proliferation ability. Proportion of EdU-positive cells was determined and statistically analysed. E, Colony formation assays were conducted in sh-KK-LC-1 HCC cells and control cells. Number of colonies was counted and shown as histogram. F, Transwell assays were used to analyse HCC cell motility. Migrated and invaded cells were quantified and statistically analysed. The data are shown as the mean ± SE. *P < 0.05, **P < 0.01, ***P < 0.001. 
| KK-LC-1 promotes HCC growth and metastasis in vivo
To explore the effects of KK-LC-1 on HCC in vivo growth, we estab- Figure 5F ). Given that EMT is an early phenotype contributing to tumour metastasis, we next constructed tail vein injection mice model to evaluate the effect of KK-LC-1 on HCC metastasis. In this model system, the incidence of both intrahepatic and pulmonary metastases in the sh-KK-LC-1 group was significantly decreased compared with the control group, whereas the KK-LC-1-OE group exhibited higher intrahepatic and pulmonary metastatic capacity compared with the control group ( Figure 6A-C) .
| KK-LC-1 activates the Notch1 signalling in HCC
Identification of the downstream signalling mediators of KK-LC-1 is crucial for understanding the mechanisms underlying KK-LC-1 regulation of HCC cells. Previous reports have indicated the significant role of Notch1 signalling in hepatic oncogenesis. 24, 25 Recent work has also implicated the activation of Notch1 signalling in CT antigen-mediated cancer progression. 28 As shown in Figure 7A , KK-LC-1 knockdown greatly attenuated the expression of NICD1 and Notch1 anti-presenilin-1 antibody ( Figure 8B ). Double immunofluorescence staining further suggested that both proteins were colocalized in the cytoplasm ( Figure 8C ). To further address the role of presenilin-1 in KK-LC-1-mediated HCC progression, we knocked down the expression of presenilin-1 using shRNA in Huh7 cells ( Figure 8D) and Huh7 KK-LC-OE cells ( Figure 8E ). We also showed that the KK-LC-1-induced Notch1 activity and EMT were restored after presenilin-1 knockdown ( Figure 8F ). Rescue experiments showed that the malignant phenotypes in KK-LC-1-OE Huh7 cells were ameliorated by presenilin-1 silencing, as observed using the CCK-8, EdU and transwell assays ( Figure 8G-I) . Taken together, these results demonstrated that KK-LC-1 promoted Notch1-mediated HCC progression through physically interacting with presenilin-1.
| CpG hypomethylation induces expression of KK-LC-1 in HCC
Previous works suggested that CT83, the gene that encodes KK-LC-1 protein, is highly hypomethylated in the basal form of breast cancer. 6,30 Therefore, we wondered whether this epigenetic regulatory mechanism existed in HCC. We analysed two gene methylation microarrays (GSE37988 and GSE57956) and two gene expression microarrays (GSE14520 and GSE25097) from GEO database to explore the relationship between CT83 DNA methylation levels and its ex- Presenilin was first identified as the site of missense mutations leading to early-onset familial Alzheimer's disease. 36, 37 The association of presenilin-1 with human malignancies has also been implicated. 38, 39 A recent study has proposed the role of presenilin-1 in facilitating HCC progression. As reported, presenilin-1 level is elevated in HCC, accompanied by increased γ-secretase activity.
| D ISCUSS I ON
Presenilin-1 promotes cell proliferation in HCC. 29 Presenilin-1-dependent γ-secretase is a crucial proteinase for Notch1 activation. In the present study, we found that KK-LC-1 physically bound to presenilin-1 and affected the downstream Notch signalling.
The Notch pathway is crucial for tissue and organ development and has been shown to participate in HCC progression.
42,43
In mammals, four types of Notch receptors (Notch1-4) have been described. Among these receptors, Notch1 is dominantly expressed in hepatocytes. 44 High Notch1 expression is associated with large tumour size, microvascular invasion and HCC metastasis. 45 Notch1 overexpression predicts an unfavourable survival outcome for liver cancer patients. 46 Our results showed that manipulation of KK-LC-1 was correlated with altered Notch activity. Inhibition of the Notch signalling by DAPT decreased the enhanced malignant phenotypes induced by KK-LC-1 overexpression, indicating that KK-LC-1 augmented HCC growth and metastasis through the Notch1 signalling.
Hypomethylated CpG islands have been reported to be associated with the activation of CT genes in several types of cancers.
CT45, a 6-member family of X-linked CT genes, is upregulated in epithelial ovarian cancer. Elevated level of CT45 expression is demonstrated to be induced by promoter hypomethylation. 47 In lung adenocarcinoma, PIWIL1 has been identified as an extremely highly expressed CT gene. Promoter DNA hypomethylation of PIWIL1 causes its overexpression. 48 In the present study, we found that hypomethylated CpG islands caused the upregulation of CT83, which is the gene that encodes KK-LC-1. We detected a lower rate of CT83 methylation in HCC samples than that in the paired non-tumorous In conclusion, we demonstrated that hypomethylation-induced KK-LC-1 facilitated HCC progression. KK-LC-1 was suggested as a prognostic indicator for HCC. Based on the mechanistic experiments, we found that KK-LC-1 physically interacted with presenilin-1 to promote the Notch1/Hes1 pathway in HCC, contributing to a better understanding of the intricate regulatory network underlying HCC pathogenesis. Targeting the KK-LC-1/presenilin-1/Notch1/ Hes1 pathway could be a candidate for molecularly targeted therapy in HCC.
CO N FLI C T O F I NTE R E S T
The authors declare that they have no conflict of interests.
AUTH O R S' CO NTR I B UTI O N S
ZQC, JDW and XHW contributed to study design; ZQC, XLZ, LYP, YZ, GYH, LZ, ZSW, WY, JJQ, XZD and HBS performed data collection and analysis; ZQC, XLZ, JDW and XHW contributed to manuscript preparation.
O RCI D
Zhiqiang Chen
https://orcid.org/0000-0003-4209-7181
